Last reviewed · How we verify
Therapeutic HBV vaccine — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Therapeutic HBV vaccine (Therapeutic HBV vaccine) — Chongqing Jiachen Biotechnology Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Therapeutic HBV vaccine TARGET | Therapeutic HBV vaccine | Chongqing Jiachen Biotechnology Ltd. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Therapeutic HBV vaccine CI watch — RSS
- Therapeutic HBV vaccine CI watch — Atom
- Therapeutic HBV vaccine CI watch — JSON
- Therapeutic HBV vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Therapeutic HBV vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/therapeutic-hbv-vaccine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab